Clinical Chemistry Analyzer HB1
- UID
- IMP/IVD/2020/001079_470cd0499a1fd5ee3b4ea0e1d980d973_6a28f347e32b5c2d3c970b33db4eb622
- Device class
- Class A
- Brand name
- Skyla
- License holder
- Kin Diagnostics
- Approving authority
- CDSCO
- Product information
- The skylaTM Clinical Chemistry Analyzer, together with its exclusive HB1 reagent disc series, offers a quick, easy and accurate method to measure various biochemical markers in whole blood, plasma, or serum. The skylaTM Clinical Chemistry Analyzer is operated in any manner different from those described in this manual, the analyzer may produce no or inaccurate results. If used outside safe design limits, the skylaTM Clinical Chemistry Analyzer may not function as intended and may be hazardous. The skylaTM Clinical Chemistry Analyzer should only be used with skylaTM HB1 series of reagent discs.
Clinical Chemistry Analyzer HB1 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/001079_470cd0499a1fd5ee3b4ea0e1d980d973_6a28f347e32b5c2d3c970b33db4eb622. This device is marketed under the brand name Skyla. The license holder is Kin Diagnostics, and it is classified as Device Class Class A. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.